Systematic review of peptic ulcer disease incidence rates: Do studies without validation provide reliable estimates?

Pharmacoepidemiology and Drug Safety

Volumn 20, Issue 7, 2011, Pages 718-728

  Lin, Kueiyu Joshua ^a,b   García Rodríguez, Luis A ^c   Hernández Díaz, Sonia ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b JACOBI MEDICAL CENTER   (United States)

^c Centro Español de Investigación Farmacoepidemiológica ^*  (Spain)

Author keywords

Bleeding; Incidence; Peptic ulcer disease; Perforation; Uncomplicated ulcer; Upper gastrointestinal complications

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

AGE; DIGESTIVE SYSTEM PERFORATION; DUODENUM BLEEDING; DUODENUM PERFORATION; GENDER; HOSPITALIZATION; HUMAN; INCIDENCE; PEPTIC ULCER; PEPTIC ULCER BLEEDING; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW;

ADULT; AGE FACTORS; AGED; DATABASES, FACTUAL; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PEPTIC ULCER; REGRESSION ANALYSIS; RISK FACTORS; SEX FACTORS; VALIDATION STUDIES AS TOPIC;

EID: 79959765566     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.2153     Document Type: Review

References (107)

1. Hernandez-Diaz S, Rodriguez LA. Incidence of serious upper gastrointestinal bleeding/perforation in the general population: review of epidemiologic studies. J Clin Epidemiol 2002; 55(2): 157-163.
2. Jick SS, Perera DR, Walker AM, Jick H. Non-steroidal anti-inflammatory drugs and hospital admission for perforated peptic ulcer. Lancet 1987; 2(8555): 380-382.
3. Bloom BS. Risk and cost of gastrointestinal side effects associated with nonsteroidal anti-inflammatory drugs. Arch Intern Med 1989; 149(5): 1019-1022.
4. Kurata JH, Honda GD, Frankl H. The incidence of duodenal and gastric ulcers in a large health maintenance organization. Am J Public Health 1985; 75(6): 625-629.
5. Perez-Aisa MA, Del Pino D, Siles M, Lanas A. Clinical trends in ulcer diagnosis in a population with high prevalence of Helicobacter pylori infection. Aliment Pharmacol Ther 2005; 21(1): 65-72.
6. Lewis JD, Bilker WB, Brensinger C, Farrar JT, Strom BL. Hospitalization and mortality rates from peptic ulcer disease and GI bleeding in the 1990s: relationship to sales of nonsteroidal anti-inflammatory drugs and acid suppression medications. Am J Gastroenterol 2002; 97(10): 2540-2549.
7. Post PN, Kuipers EJ, Meijer GA. Declining incidence of peptic ulcer but not of its complications: a nation-wide study in The Netherlands. Aliment Pharmacol Ther 2006; 23(11): 1587-1593.
8. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7(3): 177-188.
9. Yousef F, Cardwell C, Cantwell MM, Galway K, Johnston BT, Murray L. The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis. Am J Epidemiol 2008; 168(3): 237-249.
10. Cochran WG. The combination of estimates from different experiments. Biometrics 1954; 10: 101-129.
11. DESA World Population Prospects: The 2008 Revision. United Nations, Department of Economic and Social Affairs, Population Division New York, 2009.
12. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50(4): 1088-1101.
13. Cooper H, Hedges LV. The Handbook of Research Synthesis. Russel Sage Foundation: New York, 1994.
14. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315(7109): 629-634.
15. Layton D, Hughes K, Harris S, Shakir SA. Comparison of the incidence rates of selected gastrointestinal events reported for patients prescribed celecoxib and meloxicam in general practice in England using prescription-event monitoring (PEM) data. Rheumatol Oxf 2003; 42(11): 1332-1341.
16. Leoci C, Ierardi E, Chiloiro M, et al. Incidence and risk factors of duodenal ulcer. A retrospective cohort study. J Clin Gastroenterol 1995; 20(2): 104-109.
17. Anda RF, Williamson DF, Escobedo LG, Remington PL. Smoking and the risk of peptic ulcer disease among women in the United States. Arch Intern Med 1990; 150(7): 1437-1441.
18. Gyorffy Z, Adam S, Kopp M. Health status of physicians in Hungary: a representative study. Orv Hetil 2005; 146(26): 1383-1391.
19. Martin RM, Biswas P, Mann RD. The incidence of adverse events and risk factors for upper gastrointestinal disorders associated with meloxicam use amongst 19, 087 patients in general practice in England: cohort study. Br J Clin Pharmacol 2000; 50(1): 35-42.
20. Ray WA, Chung CP, Stein CM, et al. Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs. Gastroenterology 2007; 133(3): 790-798.
21. Ishikawa S, Inaba T, Mizuno M, et al. Incidence of serious upper gastrointestinal bleeding in patients taking non-steroidal anti-inflammatory drugs in Japan. Acta Med Okayama 2008; 62(1): 29-36.
22. Weideman RA, Kelly KC, Kazi S, et al. Risks of clinically significant upper gastrointestinal events with etodolac and naproxen: a historical cohort analysis. Gastroenterology 2004; 127(5): 1322-1328.
23. Biour M, Blanquart A, Moore N, et al. Incidence of NSAID-related, severe gastrointestinal bleeding. Lancet 1987; 2(8554): 340-341.
24. Garcia Rodriguez LA, Walker AM, Perez Gutthann S. Nonsteroidal antiinflammatory drugs and gastrointestinal hospitalizations in Saskatchewan: a cohort study. Epidemiology 1992; 3(4): 337-342.
25. Carson JL, Strom BL, Soper KA, West SL, Morse ML. The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding. Arch Intern Med 1987; 147(1): 85-88.
26. Gutthann SP, Garcia Rodriguez LA, Raiford DS. Individual nonsteroidal antiinflammatory drugs and other risk factors for upper gastrointestinal bleeding and perforation. Epidemiology 1997; 8(1): 18-24.
27. Laverdant C, Daly JP, Essioux H, Molinie C, Lesbre FX, Vergeau B. [Gastroduodenal ulcers in young adults. An epidemiological study (author's transl)]. Nouv Presse Méd 1980; 9(42): 3149-3152.
28. Holcombe C, Okolie H. Incidence of duodenal ulcer in the northern Savannah of Nigeria. Trop Doct 1991; 21(1): 16-18.
29. Alam MM. Incidence of duodenal ulcer and its surgical management in a teaching hospital in Bangladesh. Trop Doct 1995; 25(2): 67-68.
30. Mamdani M, Rochon PA, Juurlink DN, Kopp A, Anderson GM, Naglie G, et al. Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs. BMJ 2002; 325(7365): 624.
31. Beard K, Walker AM, Perera DR, Jick H. Nonsteroidal anti-inflammatory drugs and hospitalization for gastroesophageal bleeding in the elderly. Arch Intern Med 1987; 147(9): 1621-1623.
32. Taha AS, Angerson WJ, Knill-Jones RP, Blatchford O. Upper gastrointestinal haemorrhage associated with low-dose aspirin and anti-thrombotic drugs - a 6-year analysis and comparison with non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 2005; 22(4): 285-289.
33. Taha AS, Angerson WJ, Prasad R, McCloskey C, Blatchford O. Upper gastrointestinal bleeding and the changing use of COX-2 non-steroidal anti-inflammatory drugs and low-dose aspirin. Aliment Pharmacol Ther 2007; 26(8): 1171-1178.
34. Laporte JR, Ibanez L, Vidal X, Vendrell L, Leone R. Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents. Drug Saf 2004; 27(6): 411-420.
35. McMahon AD, Evans JM, White G, et al. A cohort study (with re-sampled comparator groups) to measure the association between new NSAID prescribing and upper gastrointestinal hemorrhage and perforation. J Clin Epidemiol 1997; 50(3): 351-356.
36. Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray WA. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991; 114(4): 257-263.
37. Rosenstock SJ, Jorgensen T. Prevalence and incidence of peptic ulcer disease in a Danish County--a prospective cohort study. Gut 1995; 36(6): 819-824.
38. Penston JG, Crombie IK, Waugh NR, Wormsley KG. Trends in morbidity and mortality from peptic ulcer disease: Tayside versus Scotland. Aliment Pharmacol Ther 1993; 7(4): 429-442.
39. Andersen IB, Bonnevie O, Jorgensen T, Sorensen TI. Time trends for peptic ulcer disease in Denmark, 1981-1993. Analysis of hospitalization register and mortality data. Scand J Gastroenterol 1998; 33(3): 260-266.
40. Christensen A, Bousfield R, Christiansen J. Incidence of perforated and bleeding peptic ulcers before and after the introduction of H2-receptor antagonists. Ann Surg 1988; 207(1): 4-6.
41. Ostensen H, Gudmundsen TE, Bolz KD, Burhol PG, Bonnevie O. The incidence of gastric ulcer and duodenal ulcer in north Norway. A prospective epidemiological study. Scand J Gastroenterol 1985; 20(2): 189-192.
42. Vreeburg EM, Snel P, de Bruijne JW, Bartelsman JF, Rauws EA, Tytgat GN. Acute upper gastrointestinal bleeding in the Amsterdam area: incidence, diagnosis, and clinical outcome. Am J Gastroenterol 1997; 92(2): 236-243.
43. Schoon IM, Mellstrom D, Oden A, Ytterberg BO. Incidence of peptic ulcer disease in Gothenburg, 1985. Bmj 1989; 299(6708): 1131-1134.
44. Hallas J, Lauritsen J, Villadsen HD, Gram LF. Nonsteroidal anti-inflammatory drugs and upper gastrointestinal bleeding, identifying high-risk groups by excess risk estimates. Scand J Gastroenterol 1995; 30(5): 438-444.
45. Ohmann C, Thon K, Hengels KJ, Imhof M. Incidence and pattern of peptic ulcer bleeding in a defined geographical area. DUSUK Study Group. Scand J Gastroenterol 1992; 27(7): 571-581.
46. Higham J, Kang JY, Majeed A. Recent trends in admissions and mortality due to peptic ulcer in England: increasing frequency of haemorrhage among older subjects. Gut 2002; 50(4): 460-464.
47. Walt R, Katschinski B, Logan R, Ashley J, Langman M. Rising frequency of ulcer perforation in elderly people in the United Kingdom. Lancet 1986; 1(8479): 489-492.
48. Coggon D, Lambert P, Langman MJ. 20years of hospital admissions for peptic ulcer in England and Wales. Lancet 1981; 1(8233): 1302-1304.
49. Thors H, Svanes C, Thjodleifsson B. Trends in peptic ulcer morbidity and mortality in Iceland. J Clin Epidemiol 2002; 55(7): 681-686.
50. Kang JY, Elders A, Majeed A, Maxwell JD, Bardhan KD. Recent trends in hospital admissions and mortality rates for peptic ulcer in Scotland 1982-2002. Aliment Pharmacol Ther 2006; 24(1): 65-79.
51. Schabowski J, Pitera J. Peptic ulcer among rural population in a selected region of south-eastern Poland. Ann Agric Environ Med 2004; 11(2): 323-327.
52. Shapira M, Tamir A. Peptic ulcer on a Kibbutz in Israel: 1930-1990. J Clin Gastroenterol 1993; 17(4): 292-295.
53. Vogt TM, Johnson RE. Recent changes in the incidence of duodenal and gastric ulcer. Am J Epidemiol 1980; 111(6): 713-720.
54. Scapa E, Horowitz M, Waron M, Eshchar J. Duodenal ulcer in the elderly. J Clin Gastroenterol 1989; 11(5): 502-506.
55. La Rosa G, Braghetto D, Di Mario F, et al. [Bleeding of gastric ulcers. Epidemiologic, clinical and functional characteristics]. Minerva Med 1990; 81(3): 185-189.
56. Hugh TB, Coleman MJ, McNamara ME, Norman JR, Howell C. Epidemiology of peptic ulcer in Australia. A study based on government statistics in four states. Med J Aust 1984; 141(2): 81-85.
57. Jibril JA, Redpath A, Macintyre IM. Changing pattern of admission and operation for duodenal ulcer in Scotland. Br J Surg 1994; 81(1): 87-89.
58. Kang JY, Tinto A, Higham J, Majeed A. Peptic ulceration in general practice in England and Wales 1994-98: period prevalence and drug management. Aliment Pharmacol Ther 2002; 16(6): 1067-1074.
59. Aro P, Storskrubb T, Ronkainen J, et al. Peptic ulcer disease in a general adult population: the Kalixanda study: a random population-based study. Am J Epidemiol 2006; 163(11): 1025-1034.
60. Segawa K, Niwa Y, Arisawa T, et al. Incidence of peptic ulcer in men is inversely correlated with blood pressure: study in an apparently healthy Japanese population. Am J Gastroenterol 1995; 90(3): 399-402.
61. Schoon IM, Mellstrom D, Oden A, Ytterberg BO. Peptic ulcer disease in older age groups in Gothenburg in 1985: the association with smoking. Age Ageing 1991; 20(5): 371-376.
62. Sonnenberg A. Birth-cohort patterns of mortality from ulcerative colitis and peptic ulcer. Ann Epidemiol 2008; 18(10): 813-819.
63. Sonnenberg A. Time trends of ulcer mortality in Europe. Gastroenterology 2007; 132(7): 2320-2327.
64. McIntosh JH, Byth K, Tsang N, Berman K, Holliday FM, Piper DW. Trends in peptic ulcer mortality in Sydney from 1971 to 1987. J Clin Gastroenterol 1993; 16(4): 346-353.
65. Kang JY. Peptic ulcer surgery in Singapore, 1951-80, with particular reference to racial differences in incidence. Aust N Z J Med 1985; 15(5): 604-608.
66. Monig SP, Brands F. Changing incidence of peptic ulcer in Germany. Eur J Epidemiol 1996; 12(6): 657-658.
67. Paimela H, Tuompo PK, Perakyl T, Saario I, Hockerstedt K, Kivilaakso E. Peptic ulcer surgery during the H2-receptor antagonist era: a population-based epidemiological study of ulcer surgery in Helsinki from 1972 to 1987. Br J Surg 1991; 78(1): 28-31.
68. Gustavsson S, Kelly KA, Melton LJ, 3rd, Zinsmeister AR. Trends in peptic ulcer surgery. A population-based study in Rochester, Minnesota, 1956-1985. Gastroenterology 1988; 94(3): 688-694.
69. Lanas A, Perez-Aisa MA, Feu F, et al. A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use. Am J Gastroenterol 2005; 100(8): 1685-1693.
70. Guess HA, West R, Strand LM, Helston D, Lydick EG, Bergman U, et al. Fatal upper gastrointestinal hemorrhage or perforation among users and nonusers of nonsteroidal anti-inflammatory drugs in Saskatchewan, Canada 1983. J Clin Epidemiol 1988; 41(1): 35-45.
71. Glynn MJ, Kane SP. Benign gastric ulceration in a health district: incidence and presentation. Postgrad Med J 1985; 61(718): 695-700.
72. Ahmed ME, al-Knaway B, al-Wabel AH, Malik GM, Foli AK. Acute upper gastrointestinal bleeding in southern Saudi Arabia. J R Coll Physicians Lond 1997; 31(1): 62-64.
73. Czernichow P, Hochain P, Nousbaum JB, et al. Epidemiology and course of acute upper gastro-intestinal haemorrhage in four French geographical areas. Eur J Gastroenterol Hepatol 2000; 12(2): 175-181.
74. Collier DS, Pain JA. Non-steroidal anti-inflammatory drugs and peptic ulcer perforation. Gut 1985; 26(4): 359-363.
75. Hermansson M, Stael von Holstein C, Zilling T. Peptic ulcer perforation before and after the introduction of H2-receptor blockers and proton pump inhibitors. Scand J Gastroenterol 1997; 32(6): 523-529.
76. Menniti-Ippolito F, Maggini M, Raschetti R, Da Cas R, Traversa G, Walker AM. Ketorolac use in outpatients and gastrointestinal hospitalization: a comparison with other non-steroidal anti-inflammatory drugs in Italy. Eur J Clin Pharmacol 1998; 54(5): 393-397.
77. Andersen IB, Jorgensen T, Bonnevie O, Gronbaek M, Sorensen TI. Smoking and alcohol intake as risk factors for bleeding and perforated peptic ulcers: a population-based cohort study. Epidemiology 2000; 11(4): 434-439.
78. Bartholomeeusen S, Vandenbroucke J, Truyers C, Buntinx F. Time trends in the incidence of peptic ulcers and oesophagitis between 1994 and 2003. Br J Gen Pract 2007; 57(539): 497-499.
79. Blatchford O, Davidson LA, Murray WR, Blatchford M, Pell J. Acute upper gastrointestinal haemorrhage in west of Scotland: case ascertainment study. BMJ 1997; 315(7107): 510-514.
80. Cutler JA, Mendeloff AI. Upper gastrointestinal bleeding. Nature and magnitude of the problem in the U.S. Dig Dis Sci 1981; 26(7 Suppl): 90S-96S.
81. Eriksen BO, Garpestad OK, Sondena H, Burhol PG. Peptic ulcer patterns in Arctic Norway. J Clin Gastroenterol 1995; 20(2): 100-103.
82. Everhart JE, Byrd-Holt D, Sonnenberg A. Incidence and risk factors for self-reported peptic ulcer disease in the United States. Am J Epidemiol 1998; 147(6): 529-536.
83. Garcia Rodriguez LA, Hernandez-Diaz S. Risk of uncomplicated peptic ulcer among users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. Am J Epidemiol 2004; 159(1): 23-31.
84. Johnsen R, Straume B, Forde OH, Burhol PG. Changing incidence of peptic ulcer--facts or artefacts? A cohort study from Tromso. J Epidemiol Community Health 1992; 46(4): 433-436.
85. Kiaer T, Roin J, Djurhuus J, Niclassen SD, Bonnevie O. Epidemiological aspects of peptic ulcer disease on the Faroe Islands. An interim report. Scand J Gastroenterol 1985; 20(9): 1157-1162.
86. Lanza LL, Walker AM, Bortnichak EA, Dreyer NA. Peptic ulcer and gastrointestinal hemorrhage associated with nonsteroidal anti-inflammatory drug use in patients younger than 65years. A large health maintenance organization cohort study. Arch Intern Med 1995; 155(13): 1371-1377.
87. Lassen A, Hallas J, Schaffalitzky de Muckadell OB. Complicated and uncomplicated peptic ulcers in a Danish county 1993-2002: a population-based cohort study. Am J Gastroenterol 2006; 101(5): 945-953.
88. Longstreth GF. Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: a population-based study. Am J Gastroenterol 1995; 90(2): 206-210.
89. MacDonald TM, Morant SV, Robinson GC, Shield MJ, McGilchrist MM, Murray FE, et al. Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study. BMJ 1997; 315(7119): 1333-1337.
90. Masson J, Bramley PN, Herd K, et al. Upper gastrointestinal bleeding in an open-access dedicated unit. J R Coll Physicians Lond 1996; 30(5): 436-442.
91. Ohmann C, Imhof M, Ruppert C, et al. Time-trends in the epidemiology of peptic ulcer bleeding. Scand J Gastroenterol 2005; 40(8): 914-920.
92. Rockall TA, Logan RF, Devlin HB, Northfield TC. Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage. BMJ 1995; 311(6999): 222-226.
93. Rosenstock S, Jorgensen T, Bonnevie O, Andersen L. Risk factors for peptic ulcer disease: a population based prospective cohort study comprising 2416 Danish adults. Gut 2003; 52(2): 186-193.
94. Smalley WE, Ray WA, Daugherty JR, Griffin MR. Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons. Am J Epidemiol 1995; 141(6): 539-545.
95. Soplepmann J, Peetsalu A, Peetsalu M, Tein A, Juhola M. Peptic ulcer haemorrhage in Tartu County, Estonia: epidemiology and mortality risk factors. Scand J Gastroenterol 1997; 32(12): 1195-1200.
96. Soplepmann J, Udd M, Peetsalu A, Palmu A. Acute upper gastrointestinal haemorrhage in Central Finland Province, Finland, and in Tartu County, Estonia. Ann Chir Gynaecol 1997; 86(3): 222-228.
97. Svanes C, Lie RT, Kvale G, Svanes K, Soreide O. Incidence of perforated ulcer in western Norway, 1935-1990: cohort- or period-dependent time trends? Am J Epidemiol 1995; 141(9): 836-844.
98. Taha AS, Angerson WJ, Prasad R, McCloskey C, Gilmour D, Morran CG. Clinical trial: the incidence and early mortality after peptic ulcer perforation, and the use of low-dose aspirin and nonsteroidal anti-inflammatory drugs. Aliment Pharmacol Ther 2008; 28(7): 878-885.
99. van Leerdam ME, Vreeburg EM, Rauws EA, et al. Acute upper GI bleeding: did anything change? Time trend analysis of incidence and outcome of acute upper GI bleeding between 1993/1994 and 2000. Am J Gastroenterol 2003; 98(7): 1494-1499.
100. Lanas A, Garcia-Rodriguez LA, Polo-Tomas M, et al. Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice. Am J Gastroenterol 2009; 104(7): 1633-1641.
101. Margulis AV, Garcia Rodriguez LA, Hernandez-Diaz S. Positive predictive value of computerized medical records for uncomplicated and complicated upper gastrointestinal ulcer. Pharmacoepidemiol Drug Saf 2009; 18.
102. Garcia Rodriguez LA, Ruigomez A. Case validation in research using large databases. Br J Gen Pract 2010; 60(572): 160-161.
103. Rockall TA, Logan RF, Devlin HB, Northfield TC. Selection of patients for early discharge or outpatient care after acute upper gastrointestinal haemorrhage. National Audit of Acute Upper Gastrointestinal Haemorrhage. Lancet 1996; 347(9009): 1138-1140.
104. Kurata JH, Elashoff JD, Haile BM, Honda GD. A reappraisal of time trends in ulcer disease: factors related to changes in ulcer hospitalization and mortality rates. Am J Public Health 1983; 73(9): 1066-1072.
105. Loffeld RJ, van der Putten AB. Changes in prevalence of Helicobacter pylori infection in two groups of patients undergoing endoscopy and living in the same region in the Netherlands. Scand J Gastroenterol 2003; 38(9): 938-941.
106. Roosendaal R, Kuipers EJ, Buitenwerf J, et al. Helicobacter pylori and the birth cohort effect: evidence of a continuous decrease of infection rates in childhood. Am J Gastroenterol 1997; 92(9): 1480-1482.
107. Sonnenberg A. Time trends of ulcer mortality in non-European countries. Am J Gastroenterol 2007; 102(5): 1101-1107.